FDA Inspection 1055806 — Kevin L. Winthrop, M.D., M.P.H.

Kevin L. Winthrop, M.D., M.P.H. — FEI 3014427418

The FDA completed an inspection of Kevin L. Winthrop, M.D., M.P.H. on Jun 14, 2018 in Portland, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 14, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Portland, OR (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent